Clinical Trial Update: Study of Cryopreserved AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of cryopreserved AURN001 for corneal edema due to corneal endothelial dysfunction is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Edema
• Corneal Endothelial Dysfunction

Drugs mentioned

• AURN001

Snippet

Sponsor: Aurion Biotech | Conditions: Corneal Edema | Phase 2 | Status: ACTIVE_NOT_RECRUITING